# Study of Albumin to Reduce Inflammation Following Surgery

> **NCT00773110** · PHASE2 · TERMINATED · sponsor: **Imperial College London** · enrollment: 232 (actual)

## Conditions studied

- Systemic Inflammatory Response Syndrome
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** 20% Human albumin solution
- **DRUG:** Gelofusin

## Key facts

- **NCT ID:** NCT00773110
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 232 (ACTUAL)
- **Why stopped:** Recruitment under target, Finding
- **Last updated:** 2014-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773110, "Study of Albumin to Reduce Inflammation Following Surgery". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00773110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*